Tharimmune Statistics
Total Valuation
Tharimmune has a market cap or net worth of $2.47 million. The enterprise value is -$2.30 million.
Market Cap | 2.47M |
Enterprise Value | -2.30M |
Important Dates
The last earnings date was Thursday, November 7, 2024.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Tharimmune has 1.15 million shares outstanding. The number of shares has increased by 2,357.50% in one year.
Current Share Class | 1.15M |
Shares Outstanding | 1.15M |
Shares Change (YoY) | +2,357.50% |
Shares Change (QoQ) | +60.82% |
Owned by Insiders (%) | 1.66% |
Owned by Institutions (%) | 2.92% |
Float | 1.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.06 |
P/TBV Ratio | 0.82 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.35
Current Ratio | 2.35 |
Quick Ratio | 2.14 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -837.16 |
Financial Efficiency
Return on equity (ROE) is -454.53% and return on invested capital (ROIC) is -291.07%.
Return on Equity (ROE) | -454.53% |
Return on Assets (ROA) | -165.08% |
Return on Capital (ROIC) | -291.07% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.62M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.95% in the last 52 weeks. The beta is 1.44, so Tharimmune's price volatility has been higher than the market average.
Beta (5Y) | 1.44 |
52-Week Price Change | -96.95% |
50-Day Moving Average | 2.49 |
200-Day Moving Average | 4.20 |
Relative Strength Index (RSI) | 44.23 |
Average Volume (20 Days) | 3,195,466 |
Short Selling Information
The latest short interest is 496,869, so 43.25% of the outstanding shares have been sold short.
Short Interest | 496,869 |
Short Previous Month | 17,697 |
Short % of Shares Out | 43.25% |
Short % of Float | 43.98% |
Short Ratio (days to cover) | 0.37 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -11.12M |
Pretax Income | -8.88M |
Net Income | -10.85M |
EBITDA | n/a |
EBIT | -11.12M |
Earnings Per Share (EPS) | -$11.95 |
Balance Sheet
Cash & Cash Equivalents | 4.77M |
Total Debt | n/a |
Net Cash | 4.77M |
Net Cash Per Share | $4.16 |
Equity (Book Value) | 3.02M |
Book Value Per Share | 2.03 |
Working Capital | 3.02M |
Cash Flow
Operating Cash Flow | -9.28M |
Capital Expenditures | n/a |
Free Cash Flow | -9.28M |
FCF Per Share | -$8.08 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Tharimmune does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2,357.50% |
Shareholder Yield | -2,357.50% |
Earnings Yield | -439.33% |
FCF Yield | -375.89% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0666667:1.
Last Split Date | May 28, 2024 |
Split Type | Reverse |
Split Ratio | 0.0666667:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |